Predictors and Risk Factors for Recurrent Scleroderma Renal Crisis in the Kidney Allograft: Case Report and Review of the Literature [PDF]
Phuong‐Thu T. Pham +9 more
openalex +1 more source
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis [PDF]
Objective. IVIG is known to confer significant benefit in rheumatologic conditions, including inflammatory myopathy. This study aimed to assess the efficacy of IVIG across different aspects of internal organ involvement in refractory active SSc ...
Denton, CP +4 more
core
A Critical Care Standpoint in the Diagnosis of Scleroderma Renal Crisis. [PDF]
Tagliaferri A +3 more
europepmc +1 more source
A Case of Renal Crisis in a Korean Scleroderma Patient with Anti-RNA polymerase I and III Antibodies [PDF]
Eun Ha Kang +7 more
openalex +1 more source
Exuberant calcinosis and acroosteolysis. A diagnostic challenge [PDF]
A case of exuberant acroosteolysis and subcutaneous tissue calcinosis in the absence of skin involvement is presented.
Ambrósio, C +4 more
core
E029 Intracranial haemorrhage in scleroderma renal crisis; an unusual presentation
Scleroderma renal crisis is a life-threatening complication of systemic sclerosis (SSc), which typically occurs in the first 5 years after disease onset.
Lucy Parker +2 more
semanticscholar +1 more source
Future targets in the management of systemic sclerosis [PDF]
CTDs—such as SSc and SLE and related rheumatic diseases such as RA—have complex, underlying pathogeneses that include fibrosis, vascular dysfunction, activation of the immune system and inflammation. Although some current therapies for SSc offer benefits
Matucci-Cerinic, M. +2 more
core
SP071ROLE OF COMPLEMENT IN SCLERODERMA RENAL CRISIS [PDF]
Anne‐Lyse Langlois +7 more
openalex +1 more source
Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis
Ney Arencibia Pérez +5 more
openalex +1 more source
Thrombotic Microangiopathy and Multiple Organ Failure in Scleroderma Renal Crisis: A Case Report. [PDF]
Aterini L +3 more
europepmc +1 more source

